Patents by Inventor Alex Brian

Alex Brian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240098158
    Abstract: A push notification mechanism at a mobile user device provides for automated limiting of the rate of production of push notification alerts (such as an audible alert or a vibratory alert) and/or push notifications responsive to the occurrence of chat events relevant to a chat application hosted by the user device. Some chat events automatically trigger suppression periods during which push notification alerts are prevented for subsequent chat events that satisfy predefined suppression criteria. Such push notification and/or alert limiting can be performed separately for separate users, chat groups, and/or chat event types.
    Type: Application
    Filed: November 30, 2023
    Publication date: March 21, 2024
    Inventors: Alex Joseph Castro, Michael Brian Murray, William Wu
  • Patent number: D706034
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: June 3, 2014
    Assignee: Glaxo Group Limited
    Inventors: Marcus Blachford, Alex Brian, Charles Drury, Rhodri Jones, Peter Kay, William Knight
  • Patent number: D706541
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: June 10, 2014
    Assignee: Glaxo Group Limited
    Inventors: Marcus Blachford, Alex Brian, Charles Drury, Peter Kay, Andrew Mitchell
  • Patent number: D712050
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: August 26, 2014
    Assignee: Glaxo Group Limited
    Inventors: Marcus Blachford, Alex Brian, Andrew Mitchell, Simon Ritchie
  • Patent number: D747882
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: January 26, 2016
    Assignee: Glaxo Group Limited
    Inventors: Marcus Blachford, Alex Brian, Charles Drury, Rhodri Jones, Peter Kay, William Knight
  • Patent number: D748398
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: February 2, 2016
    Assignee: Glaxo Group Limited
    Inventors: Marcus Blachford, Alex Brian, Charles Drury, Rhodri Jones, Peter Kay, William Knight
  • Patent number: D796208
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: September 5, 2017
    Assignee: GlaxoSmithKline Consumer Healthcare (UK) IP Limited
    Inventors: Alex Brian, Marcus Blachford, Richard Brian Clough
  • Patent number: D818823
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: May 29, 2018
    Assignee: GlaxoSmithKline Consumer Healthcare (UK) IP Limited
    Inventors: Marcus James Blachford, Alex Brian, George Cave, James Senior
  • Patent number: D828039
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: September 11, 2018
    Assignee: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
    Inventors: Marcus James Blachford, Alex Brian, Hans Kraemer, Thomas Alan Peach, Klaus Reinbold, Andrew Gordon Wallace
  • Cap
    Patent number: D840230
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: February 12, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare (UK) IP Limited
    Inventors: Marcus James Blachford, Alex Brian, James Senior
  • Patent number: D918727
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: May 11, 2021
    Assignee: GlaxoSmithKline Consumer Healthcare (UK) IP Limited
    Inventors: Marcus James Blachford, Alex Brian, Martin Crofton, Michael George, Daniel Paul Salisbury
  • Patent number: D939104
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: December 21, 2021
    Assignee: GSK CONSUMER HEALTHCARE S.A.
    Inventors: Marcus James Blachford, Stuart James King, Daniel Paul Charles Tyce, Alex Brian